- Brown’s syndrome is an uncommon strabismus characterized by restriction of elevation in adduction and can be congenital or acquired.1–3 Clinical features include mild impaired elevation on upgaze, minimal/no elevation deficit on abduction, and minimal/no superior oblique overaction.1–3
- A 25-year-old male was referred to our ophthalmology service after accidentally shooting himself in the right periocular area with a BB pellet gun. According to the patient, the gun had fired a single spherical, red plastic BB pellet approximately 5 mm in diameter. He experienced immediate decreased vision and floaters and was initially seen in a peripheral emergency department. He did not recover the BB. A computed tomography (CT) scan of the orbits performed at the peripheral hospital was reported as negative for a foreign body.
- We thank Drs. Goodhew and Thienes for sharing their comments regarding our recent article on the prescribing of medications for ocular conditions by nonophthalmologist physicians and optometrists. Our prospective study encompassed 1 year of referrals to an emergency eye clinic at a tertiary care hospital in a unique setting where 1 emergency eye service captures virtually all urgent referrals in a large region of Ontario. Within this large series a number of important findings were observed. Based on our data set, which provides only a small window on optometry prescribing, it is important that we avoid making overly specific recommendations and refrain from political commentary.
- Bevacizumab (Avastin; Genentech, San Francisco, CA, USA) and ranibizumab (Lucentis; Genentech) are both inhibitors of vascular endothelial growth factor (VEGF). They are used intravitreally in the treatment of a variety of ocular diseases including age-related macular degeneration (AMD),1,2 diabetic macular edema (DME),3–7 proliferative retinopathy,8 retinal vein occlusion,9 and others.10,11